Basic Information
LncRNA/CircRNA Name | CCAT1 |
Synonyms | CCAT1, CARLo-5, onco-lncRNA-40 |
Region | GRCh38_8:127207382-127219268 |
Ensemble | ENSG00000247844 |
Refseq | NR_108049 |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | Drug | |||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | retinoblastoma |
ICD-0-3 | C69.2 |
Methods | qPCR, RNAi, Western blot, Cell migration and invasion assay etc. |
Sample | RB tissues, cell lines (SO-RB50, Y79 and WERI-RB1) |
Expression Pattern | up-regulated |
Function Description | The expression of lncRNA CCAT1 in RB tissues was significantly increased compared with normal tissues. It was also shown that lncRNA CCAT1 in RB SORB50, Y79 and WERI-RB1 cells was significantly higher than that in normal podiatric retina. LncRNA CCAT1 promotes the proliferation migration and invasion, and reduces cell apoptosis of SO-RB50 and Y79 cells, probably through negative modulation of miR-218-5p. |
Pubmed ID | 28088735 |
Year | 2017 |
Title | Long non-coding RNA CCAT1 promotes human retinoblastoma SO-RB50 and Y79 cells through negative regulation of miR-218-5p. |
External Links
Links for CCAT1 | GenBank HGNC NONCODE |
Links for retinoblastoma | OMIM COSMIC |